TreeWAS – Variant ID: rs4345115

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H54.7 Unspecified visual loss	0.043	0.957	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.991	0.009
T42.4 Benzodiazepines	0.000	0.991	0.009
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.991	0.009
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.991	0.009
T91.3 Sequelae of injury of spinal cord	0.008	0.992	0.000
T91 Sequelae of injuries of neck and trunk	0.008	0.992	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.008	0.992	0.000
T91.9 Sequelae of unspecified injury of neck and trunk	0.007	0.993	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.993	0.007
T42.1 Iminostilbenes	0.000	0.993	0.007
T91.2 Sequelae of other fracture of thorax and pelvis	0.007	0.993	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.994	0.006
T42.2 Succinimides and oxazolidinediones	0.000	0.994	0.006
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.994	0.006
N71.9 Inflammatory disease of uterus, unspecified	0.000	0.994	0.006
T42.0 Hydantoin derivatives	0.000	0.994	0.006
C85.1 B-cell lymphoma, unspecified	0.006	0.994	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.006	0.994	0.000
T42.3 Barbiturates	0.000	0.994	0.006
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.000	0.994	0.006
H54 Blindness and low vision	0.006	0.994	0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.006	0.994	0.000
T91.4 Sequelae of injury of intrathoracic organs	0.006	0.994	0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.006	0.994	0.000
N64.8 Other specified disorders of breast	0.006	0.994	0.000
T91.1 Sequelae of fracture of spine	0.005	0.994	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.995	0.005
K10.8 Other specified diseases of jaws	0.000	0.995	0.005
H54.1 Blindness, one eye, low vision, other eye	0.005	0.995	0.000
H54.5 Low vision, one eye	0.005	0.995	0.000
L29.2 Pruritus vulvae	0.005	0.995	0.000
H54.3 Unqualified visual loss, both eyes	0.004	0.995	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.996	0.004
N28.1 Cyst of kidney, acquired	0.000	0.996	0.004
H54.6 Unqualified visual loss, one eye	0.004	0.996	0.000
J42 Unspecified chronic bronchitis	0.004	0.996	0.000
N41.9 Inflammatory disease of prostate, unspecified	0.000	0.996	0.004
R30.0 Dysuria	0.004	0.996	0.000
Z85.3 Personal history of malignant neoplasm of breast	0.004	0.996	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.004	0.996	0.000
H54.0 Blindness, both eyes	0.004	0.996	0.000
H54.9 Unspecified visual impairment (binocular)	0.004	0.996	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.004	0.996	0.000
H52.0 Hypermetropia	0.000	0.996	0.004
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.004	0.996	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.996	0.004
N11.1 Chronic obstructive pyelonephritis	0.004	0.996	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.004	0.996	0.000
Y83.9 Surgical procedure, unspecified	0.004	0.996	0.000
H54.2 Low vision, both eyes	0.003	0.996	0.000
K22.1 Ulcer of oesophagus	0.000	0.996	0.004
H50.4 Other and unspecified heterotropia	0.000	0.996	0.004
C45.0 Mesothelioma of pleura	0.000	0.996	0.004
N11 Chronic tubulo-interstitial nephritis	0.003	0.997	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.997	0.003
H50.0 Convergent concomitant strabismus	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
T92 Sequelae of injuries of upper limb	0.003	0.997	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.003	0.997	0.000
H52.3 Anisometropia and aniseikonia	0.000	0.997	0.003
C85.0 Lymphosarcoma	0.003	0.997	0.000
I50.9 Heart failure, unspecified	0.000	0.997	0.003
R27.0 Ataxia, unspecified	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.003	0.997	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.003	0.997	0.000
E88.8 Other specified metabolic disorders	0.000	0.997	0.003
N13.4 Hydroureter	0.003	0.997	0.000
M35.0 Sicca syndrome [Sjogren]	0.000	0.997	0.003
E88 Other metabolic disorders	0.000	0.997	0.003
L73.2 Hidradenitis suppurativa	0.000	0.997	0.003
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
F10.0 Acute intoxication	0.000	0.997	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
T46.7 Peripheral vasodilators	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.003
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.997	0.003
T43.2 Other and unspecified antidepressants	0.000	0.997	0.003
Q61.2 Polycystic kidney, adult type	0.000	0.997	0.003
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.003	0.997	0.000
K10 Other diseases of jaws	0.000	0.997	0.003
H52 Disorders of refraction and accommodation	0.000	0.997	0.003
Q61.3 Polycystic kidney, unspecified	0.000	0.997	0.003
D09.0 Bladder	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
H50 Other strabismus	0.000	0.997	0.003
T92.9 Sequelae of unspecified injury of upper limb	0.003	0.997	0.000
N71 Inflammatory disease of uterus, except cervix	0.000	0.997	0.003
K10.0 Developmental disorders of jaws	0.000	0.997	0.003
M79.84 Other specified soft tissue disorders (Hand)	0.003	0.997	0.000
N11.8 Other chronic tubulo-interstitial nephritis	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
Q50.4 Embryonic cyst of Fallopian tube	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
T63.4 Venom of other arthropods	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T45.5 Anticoagulants	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
E88.1 Lipodystrophy, not elsewhere classified	0.000	0.997	0.003
T92.4 Sequelae of injury of nerve of upper limb	0.003	0.997	0.000
E88.2 Lipomatosis, not elsewhere classified	0.000	0.997	0.003
K10.3 Alveolitis of jaws	0.000	0.997	0.003
I47.9 Paroxysmal tachycardia, unspecified	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.002
T45.4 Iron and its compounds	0.000	0.997	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.002
H21.8 Other specified disorders of iris and ciliary body	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.000	0.997	0.002
N50.0 Atrophy of testis	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.002
M79.8 Other specified soft tissue disorders	0.003	0.997	0.000
Q61 Cystic kidney disease	0.000	0.997	0.003
N71.1 Chronic inflammatory disease of uterus	0.000	0.997	0.002
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.002	0.998	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
H50.2 Vertical strabismus	0.000	0.998	0.002
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
E88.9 Metabolic disorder, unspecified	0.000	0.998	0.002
H49.1 Fourth [trochlear] nerve palsy	0.000	0.998	0.002
H52.6 Other disorders of refraction	0.000	0.998	0.002
H52.5 Disorders of accommodation	0.000	0.998	0.002
K10.1 Giant cell granuloma, central	0.000	0.998	0.002
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.000	0.998	0.002
E88.3 Tumour lysis syndrome	0.000	0.998	0.002
K10.2 Inflammatory conditions of jaws	0.000	0.998	0.002
Q61.9 Cystic kidney disease, unspecified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.002	0.998	0.000
H50.3 Intermittent heterotropia	0.000	0.998	0.002
H52.2 Astigmatism	0.000	0.998	0.002
K75.9 Inflammatory liver disease, unspecified	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
Q61.0 Congenital single renal cyst	0.000	0.998	0.002
R27.8 Other and unspecified lack of coordination	0.002	0.998	0.000
R30 Pain associated with micturition	0.002	0.998	0.000
C45.7 Mesothelioma of other sites	0.000	0.998	0.002
H50.6 Mechanical strabismus	0.000	0.998	0.002
R30.1 Vesical tenesmus	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
M79.81 Other specified soft tissue disorders (Shoulder region)	0.002	0.998	0.000
I49.5 Sick sinus syndrome	0.000	0.998	0.002
K75.0 Abscess of liver	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
C45 Mesothelioma	0.000	0.998	0.002
T95 Sequelae of burns, corrosions and frostbite	0.002	0.998	0.000
H50.8 Other specified strabismus	0.000	0.998	0.002
H52.7 Disorder of refraction, unspecified	0.000	0.998	0.002
N13.9 Obstructive and reflux uropathy, unspecified	0.002	0.998	0.000
T92.0 Sequelae of open wound of upper limb	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
H49 Paralytic strabismus	0.000	0.998	0.002
R27 Other lack of coordination	0.002	0.998	0.000
H52.4 Presbyopia	0.000	0.998	0.002
H54.4 Blindness, one eye	0.002	0.998	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
I47.2 Ventricular tachycardia	0.002	0.998	0.000
K10.9 Disease of jaws, unspecified	0.000	0.998	0.002
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.002	0.998	0.000
Q61.8 Other cystic kidney diseases	0.000	0.998	0.002
Q61.1 Polycystic kidney, infantile type	0.000	0.998	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
T95.8 Sequelae of other specified burn, corrosion and frostbite	0.002	0.998	0.000
S62.51 Fracture of thumb (open)	0.000	0.998	0.002
T92.1 Sequelae of fracture of arm	0.002	0.998	0.000
T95.0 Sequelae of burn, corrosion and frostbite of head and neck	0.002	0.998	0.000
N71.0 Acute inflammatory disease of uterus	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
R18 Ascites	0.000	0.998	0.002
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.002	0.998	0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.002	0.998	0.000
H61.0 Perichondritis of external ear	0.000	0.998	0.002
K75.4 Autoimmune hepatitis	0.000	0.998	0.002
S46.2 Injury of muscle and tendon of other parts of biceps	0.000	0.998	0.002
M79.88 Other specified soft tissue disorders (Other)	0.002	0.998	0.000
T39.0 Salicylates	0.000	0.998	0.002
S62.50 Fracture of thumb (closed)	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
M79.82 Other specified soft tissue disorders (Upper arm)	0.002	0.998	0.000
G59.0 Diabetic mononeuropathy	0.002	0.998	0.000
H50.5 Heterophoria	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
C32.0 Glottis	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
U51 Admission status on psychiatric patients	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
Q61.4 Renal dysplasia	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.002	0.998	0.000
H35.9 Retinal disorder, unspecified	0.002	0.998	0.000
Z87.2 Personal history of diseases of the skin and subcutaneous tissue	0.000	0.998	0.002
M79.89 Other specified soft tissue disorders (Site unspecified)	0.002	0.998	0.000
K42.9 Umbilical hernia without obstruction or gangrene	0.000	0.998	0.002
Q61.5 Medullary cystic kidney	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
N13 Obstructive and reflux uropathy	0.002	0.998	0.000
C45.2 Mesothelioma of pericardium	0.000	0.998	0.002
C45.1 Mesothelioma of peritoneum	0.000	0.998	0.002
H51 Other disorders of binocular movement	0.000	0.998	0.002
K75 Other inflammatory liver diseases	0.000	0.998	0.002
T95.9 Sequelae of unspecified burn, corrosion and frostbite	0.002	0.998	0.000
T95.4 Sequelae of burn and corrosion classifiable only according to extent of body surface involved	0.002	0.998	0.000
T95.1 Sequelae of burn, corrosion and frostbite of trunk	0.002	0.998	0.000
W21.9 Unspecified place	0.000	0.998	0.002
N13.7 Vesicoureteral-reflux-associated uropathy	0.002	0.998	0.000
H49.3 Total (external) ophthalmoplegia	0.000	0.998	0.002
H49.0 Third [oculomotor] nerve palsy	0.000	0.998	0.002
H50.9 Strabismus, unspecified	0.000	0.998	0.002
Z71.8 Other specified counselling	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
L08.8 Other specified local infections of skin and subcutaneous tissue	0.002	0.998	0.000
T95.3 Sequelae of burn, corrosion and frostbite of lower limb	0.002	0.998	0.000
T95.2 Sequelae of burn, corrosion and frostbite of upper limb	0.002	0.998	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.000	0.998	0.002
E74.3 Other disorders of intestinal carbohydrate absorption	0.002	0.998	0.000
H49.2 Sixth [abducent] nerve palsy	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
S22.40 Multiple fractures of ribs (closed)	0.000	0.998	0.002
C45.9 Mesothelioma, unspecified	0.000	0.998	0.002
H49.8 Other paralytic strabismus	0.000	0.998	0.001
H49.4 Progressive external ophthalmoplegia	0.000	0.998	0.001
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.002
N10-N16 Renal tubulo-interstitial diseases	0.002	0.998	0.000
O86.0 Infection of obstetric surgical wound	0.000	0.998	0.002
R63.1 Polydipsia	0.000	0.998	0.002
K50.1 Crohn's disease of large intestine	0.000	0.998	0.002
R30.9 Painful micturition, unspecified	0.002	0.998	0.000
T51.9 Alcohol, unspecified	0.000	0.998	0.002
T98 Sequelae of other and unspecified effects of external causes	0.002	0.998	0.000
H51.9 Disorder of binocular movement, unspecified	0.000	0.998	0.001
H51.8 Other specified disorders of binocular movement	0.000	0.998	0.001
H51.1 Convergence insufficiency and excess	0.000	0.998	0.001
H51.0 Palsy of conjugate gaze	0.000	0.998	0.001
K75.2 Nonspecific reactive hepatitis	0.000	0.998	0.001
K75.1 Phlebitis of portal vein	0.000	0.998	0.001
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.001
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.001
N13.6 Pyonephrosis	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.001
K74.5 Biliary cirrhosis, unspecified	0.000	0.998	0.002
S62.5 Fracture of thumb	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.001
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.001	0.998	0.000
T94 Sequelae of injuries involving multiple and unspecified body regions	0.001	0.998	0.000
M79.83 Other specified soft tissue disorders (Forearm)	0.001	0.998	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.998	0.001
N64 Other disorders of breast	0.002	0.998	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.001
B18.2 Chronic viral hepatitis C	0.000	0.998	0.002
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.002	0.998	0.000
S91.1 Open wound of toe(s) without damage to nail	0.000	0.998	0.002
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.000	0.998	0.002
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.001	0.998	0.000
N64.2 Atrophy of breast	0.001	0.998	0.000
S64.2 Injury of radial nerve at wrist and hand level	0.000	0.998	0.002
O86.1 Other infection of genital tract following delivery	0.000	0.998	0.001
S32.0 Fracture of lumbar vertebra	0.000	0.998	0.001
H49.9 Paralytic strabismus, unspecified	0.000	0.999	0.001
H51.2 Internuclear ophthalmoplegia	0.000	0.999	0.001
T75.4 Effects of electric current	0.000	0.999	0.001
S46.0 Injury of tendon of the rotator cuff of shoulder	0.000	0.999	0.001
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.001	0.999	0.000
Q50.5 Embryonic cyst of broad ligament	0.000	0.999	0.001
Z42.1 Follow-up care involving plastic surgery of breast	0.001	0.999	0.000
D03.4 Melanoma in situ of scalp and neck	0.000	0.999	0.001
I78.1 Naevus, nonneoplastic	0.001	0.999	0.000
T98.2 Sequelae of certain early complications of trauma	0.001	0.999	0.000
T98.0 Sequelae of effects of foreign body entering through natural orifice	0.001	0.999	0.000
M13.93 Arthritis, unspecified (Forearm)	0.001	0.999	0.000
N64.3 Galactorrhoea not associated with childbirth	0.001	0.999	0.000
T63 Toxic effect of contact with venomous animals	0.000	0.999	0.001
Z33 Pregnant state, incidental	0.001	0.999	0.000
M79.80 Other specified soft tissue disorders (Multiple sites)	0.001	0.999	0.000
N14.4 Toxic nephropathy, not elsewhere classified	0.001	0.999	0.000
N14.3 Nephropathy induced by heavy metals	0.001	0.999	0.000
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.001	0.999	0.000
N14.0 Analgesic nephropathy	0.001	0.999	0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.000	0.999	0.001
Q50.3 Other congenital malformations of ovary	0.000	0.999	0.001
Q50.2 Congenital torsion of ovary	0.000	0.999	0.001
Q50.1 Developmental ovarian cyst	0.000	0.999	0.001
Q50.0 Congenital absence of ovary	0.000	0.999	0.001
B18.1 Chronic viral hepatitis B without delta-agent	0.000	0.999	0.001
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.001	0.999	0.000
N64.0 Fissure and fistula of nipple	0.001	0.999	0.000
O86.2 Urinary tract infection following delivery	0.000	0.999	0.001
I47 Paroxysmal tachycardia	0.001	0.999	0.000
T94.0 Sequelae of injuries involving multiple body regions	0.001	0.999	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.001	0.999	0.000
O86 Other puerperal infections	0.000	0.999	0.001
S32.01 Fracture of lumbar vertebra (open)	0.000	0.999	0.001
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.001	0.999	0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.001	0.999	0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.001	0.999	0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.001	0.999	0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.001	0.999	0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.001	0.999	0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.001	0.999	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
S92.40 Fracture of great toe (closed)	0.000	0.999	0.001
M35.1 Other overlap syndromes	0.000	0.999	0.001
N64.1 Fat necrosis of breast	0.001	0.999	0.000
T98.1 Sequelae of other and unspecified effects of external causes	0.001	0.999	0.000
N64.4 Mastodynia	0.001	0.999	0.000
T63.8 Toxic effect of contact with other venomous animals	0.000	0.999	0.001
T63.6 Toxic effect of contact with other marine animals	0.000	0.999	0.001
T63.5 Toxic effect of contact with fish	0.000	0.999	0.001
T63.3 Venom of spider	0.000	0.999	0.001
T63.2 Venom of scorpion	0.000	0.999	0.001
T63.1 Venom of other reptiles	0.000	0.999	0.001
T63.0 Snake venom	0.000	0.999	0.001
Y54.3 Benzothiadiazine derivatives	0.001	0.999	0.000
S92.70 Multiple fractures of foot (closed)	0.000	0.999	0.001
I45.1 Other and unspecified right bundle-branch block	0.001	0.999	0.000
S21.9 Open wound of thorax, part unspecified	0.000	0.999	0.001
D09 Carcinoma in situ of other and unspecified sites	0.001	0.999	0.000
G93.9 Disorder of brain, unspecified	0.000	0.999	0.001
H21.0 Hyphaema	0.001	0.999	0.000
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge	0.001	0.999	0.000
O86.8 Other specified puerperal infections	0.000	0.999	0.001
O86.3 Other genito-urinary tract infections following delivery	0.000	0.999	0.001
C06.9 Mouth, unspecified	0.001	0.999	0.000
S21.1 Open wound of front wall of thorax	0.000	0.999	0.001
N15 Other renal tubulo-interstitial diseases	0.001	0.999	0.000
I47.0 Reentry ventricular arrhythmia	0.001	0.999	0.000
M67.2 Synovial hypertrophy, not elsewhere classified	0.001	0.999	0.000
C18.0 Caecum	0.000	0.999	0.001
C53.9 Cervix uteri, unspecified	0.001	0.999	0.000
J31.0 Chronic rhinitis	0.000	0.999	0.001
O86.4 Pyrexia of unknown origin following delivery	0.000	0.999	0.001
T63.9 Toxic effect of contact with unspecified venomous animal	0.000	0.999	0.001
Z43.6 Attention to other artificial openings of urinary tract	0.000	0.999	0.001
D09.9 Carcinoma in situ, unspecified	0.001	0.999	0.000
D09.7 Carcinoma in situ of other specified sites	0.001	0.999	0.000
D09.3 Thyroid and other endocrine glands	0.001	0.999	0.000
D09.2 Eye	0.001	0.999	0.000
M51.9 Intervertebral disk disorder, unspecified	0.000	0.999	0.001
T98.3 Sequelae of complications of surgical and medical care, not elsewhere classified	0.001	0.999	0.000
S72.00 Fracture of neck of femur (closed)	0.000	0.999	0.001
D09.1 Other and unspecified urinary organs	0.001	0.999	0.000
N15.8 Other specified renal tubulo-interstitial diseases	0.001	0.999	0.000
N15.0 Balkan nephropathy	0.001	0.999	0.000
N91.2 Amenorrhoea, unspecified	0.000	0.999	0.001
S46.1 Injury of muscle and tendon of long head of biceps	0.000	0.999	0.001
Z43.4 Attention to other artificial openings of digestive tract	0.000	0.999	0.001
Z58.1 Exposure to air pollution	0.000	0.999	0.001
Z71.2 Person consulting for explanation of investigation findings	0.001	0.999	0.000
S46 Injury of muscle and tendon at shoulder and upper arm level	0.000	0.999	0.001
M41.86 Other forms of scoliosis (Lumbar region)	0.000	0.999	0.001
M43.62 Torticollis-Cervical	0.001	0.999	0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.001	0.999	0.000
J45.0 Predominantly allergic asthma	0.000	0.999	0.001
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.000	0.999	0.001
A49.9 Bacterial infection, unspecified	0.001	0.999	0.000
H21.4 Pupillary membranes	0.001	0.999	0.000
S91.2 Open wound of toe(s) with damage to nail	0.000	0.999	0.001
T75.1 Drowning and nonfatal submersion	0.000	0.999	0.001
Y43.4 Immunosuppressive agents	0.000	0.999	0.001
Y54.8 Agents affecting uric acid metabolism	0.001	0.999	0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.001	0.999	0.000
A49.8 Other bacterial infections of unspecified site	0.001	0.999	0.000
N13.3 Other and unspecified hydronephrosis	0.001	0.999	0.000
W10.8 Other specified place	0.000	0.999	0.001
M35.7 Hypermobility syndrome	0.000	0.999	0.001
Q79.6 Ehlers-Danlos syndrome	0.001	0.999	0.000
S46.7 Injury of multiple muscles and tendons at shoulder and upper arm level	0.000	0.999	0.001
T94.1 Sequelae of injuries, not specified by body region	0.001	0.999	0.000
U80.0 Penicillin resistant agent	0.000	0.999	0.001
H21 Other disorders of iris and ciliary body	0.001	0.999	0.000
C83.3 Large cell (diffuse)	0.001	0.999	0.000
G95.0 Syringomyelia and syringobulbia	0.001	0.999	0.000
H21.2 Degeneration of iris and ciliary body	0.001	0.999	0.000
N27.0 Small kidney, unilateral	0.001	0.999	0.000
O23.5 Infections of the genital tract in pregnancy	0.001	0.999	0.000
X41.9 Unspecified place	0.000	0.999	0.001
B18 Chronic viral hepatitis	0.000	0.999	0.001
N41 Inflammatory diseases of prostate	0.000	0.999	0.001
S92.41 Fracture of great toe (open)	0.000	0.999	0.001
D03.6 Melanoma in situ of upper limb, including shoulder	0.000	0.999	0.001
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.999	0.001
H21.3 Cyst of iris, ciliary body and anterior chamber	0.001	0.999	0.000
M35.8 Other specified systemic involvement of connective tissue	0.000	0.999	0.001
N76.4 Abscess of vulva	0.000	0.999	0.001
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.001	0.999	0.000
S29.9 Unspecified injury of thorax	0.000	0.999	0.001
Y54.5 Other diuretics	0.001	0.999	0.000
B18.8 Other chronic viral hepatitis	0.000	0.999	0.001
B18.0 Chronic viral hepatitis B with delta-agent	0.000	0.999	0.001
I45.6 Preexcitation syndrome	0.000	0.999	0.001
N41.3 Prostatocystitis	0.000	0.999	0.001
N41.2 Abscess of prostate	0.000	0.999	0.001
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.999	0.001
W02.9 Unspecified place	0.001	0.999	0.000
Z58.7 Exposure to tobacco smoke	0.000	0.999	0.001
M35 Other systemic involvement of connective tissue	0.000	0.999	0.001
H01.0 Blepharitis	0.000	0.999	0.001
H50.1 Divergent concomitant strabismus	0.000	0.999	0.001
J93.9 Pneumothorax, unspecified	0.000	0.999	0.001
L29.3 Anogenital pruritus, unspecified	0.001	0.999	0.000
N15.9 Renal tubulo-interstitial disease, unspecified	0.001	0.999	0.000
N15.1 Renal and perinephric abscess	0.001	0.999	0.000
O24.9 Diabetes mellitus in pregnancy, unspecified	0.001	0.999	0.000
S22.4 Multiple fractures of ribs	0.000	0.999	0.001
S21 Open wound of thorax	0.000	0.999	0.001
M23.21 Derangement of meniscus due to old tear or injury (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.999	0.001
S22.41 Multiple fractures of ribs (open)	0.000	0.999	0.001
F42.0 Predominantly obsessional thoughts or ruminations	0.001	0.999	0.000
F43.9 Reaction to severe stress, unspecified	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations